Open Opportunities for Research
All federal cannabis research is approved by and limited to the constraints of the mission of the National Institute on Drug Abuse (NIDA). As a result, the U.S. lags behind other first world nations in the use of cannabis-based medicines in a wide variety of delivery methods. Legal marijuana states, starting with California in 1996, as well as other nations such as Israel, are on the cutting edge of important discoveries about the way cannabis interacts with humans. We open opportunities for research in the study of things like:
- Cancer – There is a growing body of study that shows cannabis kills many types of cancer, including one posted to the NIH December 24 on CBD Extract and colon cancer.
- TBI- Administered immediately after a traumatic brain injury, cannabis is showing promise in reducing swelling and protecting delicate, injured brain cells from further damage.
- Epilepsy – Amazing results are being reported by people suffering with seizures. Cannabis is reducing and sometimes even eliminating seizures where legal. Keeping medical cannabis from epilepsy patients is wrong, especially considering the side effects and expense of lesser medications.